secwatch.observer — SEC 8-K summary
======================================

Issuer:     PMGC Holdings Inc. (ELAB)
CIK:        0001840563
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001213900-25-038049
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PMGC subsidiary Northstrive files four new patent applications for EL-22 and EL-32 programs
--------------------------------------------------------------------------------

- Filing covers EL-22 in animals (App. 19/191,246) and EL-32 in obesity as monotherapy and with GLP-1 combos.
- New patents also include EL-32 animal feed additive (App. 19/191,258) for muscle growth.
- Northstrive's IP portfolio now totals 8 applications and 5 issued patents covering USA, Japan, Korea, China.
- The filings aim to preserve muscle mass during obesity treatment and expand into animal health market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840563/000121390025038049/0001213900-25-038049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840563/000121390025038049/ea0240193-8k_pmgc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-038049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer